Global SERD Therapeutics Market

Report ID : 1246 | Published : 2022-06-07 | Pages: | Format:

The Global SERD (selective estrogen receptor degrader) Therapeutics Market size was accounted at USD 1.3 Bn in 2021; It is projected to grow at a compound annual growth rate (CAGR) of 17.9% from 2022 to 2030. Selective estrogen receptor degrader (SERD) is a type of drug which downregulates the estrogen receptor. SERD treats estrogen receptor-positive breast cancer. SERD therapy can be used as both monotherapies and in combination with other therapeutic agents. Many key market players are engaged in developing new breast cancer therapies that would propel the growth of this market.

Major driving factors in the SERD therapeutics market are the increasing need for SERD therapies, the high prevalence of breast cancer, the rising number of clinical trials, and increasing investments by key players in the development of promising treatments. Furthermore, advanced medical technologies, growth in the population, and a growing number of health-conscious people will enhance the growth of the SERD therapeutics market during the forecast period. However, the high price of devices, complex procedures, lack of strict government laws, and resistance to endocrine Therapy are limiting the growth of this market.

The SERD therapeutics market is segmented into Products, Therapy and Region. The Products segment is further bifurcated into Faslodex, RAD1901, GDC-9545, AZD9833, SAR439859, and Other Generics. SAR439859 is expected to dominate this market over the forecast period due to its safety and efficacy. By Therapy, the market is segmented into First-Line Treatment and Second-Line Treatment. Regionally, the SERD therapeutics market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America, followed by Europe, holds the maximum share of this market due to increased research and development expenditure, major market players, and the fast adaption of advanced technologies.

Major vital Players in the SERD therapeutics market are Amneal Pharmaceuticals Inc, AstraZeneca, Plc., Dr Reddy’s Laboratories, Eli Lilly and Company, G1 Therapeutics, Inc., Glenmark Pharmaceuticals, HBT Labs, Inc, Hoffmann-La Roche AG, InventisBio, Novartis AG, Radius Health, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Zenopharm LLC., Zentalis Pharmaceuticals, and List of Other Prominent Players.

Companies Mentioned

  • Amneal Pharmaceuticals Inc
  • AstraZeneca, Plc.
  • Reddy’s Laboratories
  • Eli Lilly and Company
  • G1 Therapeutics, Inc.
  • Glenmark Pharmaceuticals
  • HBT Labs, Inc
  • Hoffmann-La Roche AG
  • InventisBio
  • Novartis AG
  • Radius Health
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Zenopharm LLC.
  • Zentalis Pharmaceuticals
  • List of Other Prominent Players

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global SERD Therapeutics Market Snapshot

Chapter 4. Global SERD Therapeutics Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Key Trends in the Market

4.8. COVID 19 Impact Analysis

4.9. Clinical Trial/Pipeline Analysis

Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis

5.1. By Products & Market Share, 2020 & 2030

5.2. Market Size (Value) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Products:

5.2.1. Faslodex

5.2.2. RAD1901

5.2.3. GDC-9545

5.2.4. AZD9833

5.2.5. SAR439859

5.2.6. Other Generics

Chapter 6. SERD Therapeutics Market Segmentation 2: By Therapy Estimates & Trend Analysis

6.1. By Therapy Analysis & Market Share, 2020 & 2030

6.2. Market Size (Value) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Therapy:

6.2.1. First-Line Treatment

6.2.2. Second-Line Treatment

Chapter 7. SERD Therapeutics Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America SERD Therapeutics Market revenue (US$ Million) estimates and forecasts By Products, 2020-2030

7.1.2. North America SERD Therapeutics Market revenue (US$ Million) estimates and forecasts By Products, 2020-2030

7.1.3. North America SERD Therapeutics Market revenue (US$ Million) estimates and forecasts By Therapy, 2020-2030

7.1.4. North America SERD Therapeutics Market revenue (US$ Million) estimates and forecasts by country, 2020-2030

7.1.4.1. U.S.

7.1.4.2. Canada

7.2. Europe

7.2.1. Europe SERD Therapeutics Market revenue (US$ Million) By Products, 2020-2030

7.2.2. Europe SERD Therapeutics Market revenue (US$ Million) By Products, 2020-2030

7.2.3. Europe SERD Therapeutics Market revenue (US$ Million) By Therapy, 2020-2030

7.2.4. Europe SERD Therapeutics Market revenue (US$ Million) By country, 2020-2030

7.2.4.1. Germany

7.2.4.2. Poland

7.2.4.3. France

7.2.4.4. Italy

7.2.4.5. Spain

7.2.4.6. UK

7.2.4.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific SERD Therapeutics Market revenue (US$ Million) By Products, 2020-2030

7.3.2. Asia Pacific SERD Therapeutics Market revenue (US$ Million) By Products, 2020-2030

7.3.3. Asia Pacific SERD Therapeutics Market revenue (US$ Million) By Therapy, 2020-2030

7.3.4. Asia Pacific SERD Therapeutics Market revenue (US$ Million) By country, 2020-2030

7.3.4.1. China

7.3.4.2. India

7.3.4.3. Japan

7.3.4.4. Australia

7.3.4.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America SERD Therapeutics Market revenue (US$ Million) By Products, (US$ Million) 2020-2030

7.4.2. Latin America SERD Therapeutics Market revenue (US$ Million) By Products, (US$ Million) 2020-2030

7.4.3. Latin America SERD Therapeutics Market revenue (US$ Million) By Therapy, (US$ Million) 2020-2030

7.4.4. Latin America SERD Therapeutics Market revenue (US$ Million) By country, (US$ Million) 2020-2030

7.4.4.1. Brazil

7.4.4.2. Rest of Latin America

7.5. MEA

7.5.1. MEA revenue SERD Therapeutics Market revenue (US$ Million) By Products, (US$ Million) 2020-2030

7.5.2. MEA revenue SERD Therapeutics Market revenue (US$ Million) By Products, (US$ Million) 2020-2030

7.5.3. MEA revenue SERD Therapeutics Market revenue (US$ Million) By Therapy, (US$ Million) 2020-2030

7.5.4. MEA revenue SERD Therapeutics Market revenue (US$ Million) By country, (US$ Million) 2020-2030

7.5.4.1. South Africa

7.5.4.2. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles 

8.2.1. Amneal Pharmaceuticals Inc

8.2.2. AstraZeneca, Plc.

8.2.3. Dr. Reddy’s Laboratories

8.2.4. Eli Lilly and Company

8.2.5. G1 Therapeutics, Inc.

8.2.6. Glenmark Pharmaceuticals

8.2.7. HBT Labs, Inc

8.2.8. Hoffmann-La Roche AG

8.2.9. InventisBio

8.2.10. Novartis AG

8.2.11. Radius Health

8.2.12. Sanofi S.A.

8.2.13. Teva Pharmaceutical Industries Ltd.

8.2.14. Zenopharm LLC.

8.2.15. Zentalis Pharmaceuticals

8.3. List of Other Prominent Players

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Products

  • Faslodex
  • RAD1901
  • GDC-9545
  • AZD9833
  • SAR439859
  • Other Generics

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Therapy

  • First-Line Treatment
  • Second-Line Treatment

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America SERD therapeutics market revenue (US$ Million) by Country, 2020 to 2030

  • U.S.
  • Canada

Europe SERD therapeutics market revenue (US$ Million) by Country, 2020 to 2030

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific SERD therapeutics market revenue (US$ Million) by Country, 2020 to 2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America SERD therapeutics market revenue (US$ Million) by Country, 2020 to 2030

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa SERD therapeutics market revenue (US$ Million) by Country, 2020 to 2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development

Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients